首頁用資料

首頁用資料

Our Track Record

Our Track Record

FDA/EMA/PMDA/TFDA GMP Standard Compliance
Grow together

Grow together

The most experienced technical team will bring the greatest benefits to customers and patients

The primary task

The primary task

We hope patients can use affordable high-quality biological drugs

Drug development

Drug development

Assist customers to go faster and further on the journey of biotechnology drug development, because successfully developed drugs can bring more protection to human health

2012

2012

12.21

ISO 14001:2015 Certified

ISO 14001:2015 Certified

A comprehensive environmental management system is in place, ensuring compliance with international environmental standards.

25–35% Wastewater Recycled

25–35% Wastewater Recycled

RO-treated process wastewater is reused in cooling towers, enabling effective water resource recycling.

Renewable Energy Usage Reaches 16.8%

Renewable Energy Usage Reaches 16.8%

The share of green energy increased from 12.7% to 16.8% through solar power generation and green electricity procurement.

Product & Pipeline

Product & Pipeline

EirGenix Inc. focuses on the development of biologics, including monoclonal antibodies and antibody-drug conjugates (ADCs), supported by a fully integrated R&D and GMP manufacturing platform.

Contact Us

Contact Us

 

Our professional team is always ready to address all your concerns.